HeartBeam (NASDAQ: BEAT) was featured in a recent article that discussed its collaboration with Mount Sinai aimed at ...
Hosted on MSN
Prehospital ECG linked to lower cardiac mortality
Studies show that performing 12-lead ECGs before hospital arrival improves acute coronary syndrome care, reducing mortality and enabling faster interventions. Detecting ischemia early can identify ...
HeartBeam (NASDAQ: BEAT) was featured in a recent article that discussed its collaboration with Mount Sinai aimed at ...
Key market opportunities in the global electrocardiograph (ECG) sector include rising demand for wearable and portable ECG ...
Collaborates To Advance Next-Gen ECG Solutions. HeartBeam (NASDAQ: BEAT) was featured in a recent article that discussed its collaboration with Mount Sinai aimed at advancing artificial ...
A fit Bengaluru executive's heart attack despite normal tests reveals how standard ECGs and cholesterol checks miss hidden ...
At HRS 2026, Dr. Song Zuo presented evidence that AI can detect atrial fibrillation with over 90% sensitivity, ...
Elite footballers of Black ethnicity show important ancestry-related differences in cardiac adaptation. These results were ...
On April 15, Kim Bolton, President & Portfolio Manager at Black Swan Dexteritas, appeared on BNN Bloomberg to share his ...
Key take-awaysAn observational study investigated parameters associated with sudden cardiac death across more than 9,000 elite male football (soccer ...
Elite footballers of Black ethnicity show important ancestry-related differences in cardiac adaptation. These results were ...
Ziftomenib was approved by the U.S. Food and Drug Administration (FDA) in November 2025 for the treatment of adult patients with R/R NPM1 -m AML who have no satisfactory alternative treatment options, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results